SEARCH

SEARCH BY CITATION

References

  • ALMAZAN, G., AFAR, D.E.H. & BELL, J.C. (1993). Phosphorylation and disruption of intermediate filament proteins in oligodendrocyte precursor cultures treated with calyculin A. J. Neurosci. Res., 36, 163172.
  • BELACHEW, S., ROGISTER, B., RIGO, J.M., MALGRANGE, B. & MOONEN, G. (1999). Neurotransmitter mediated regulation of CNS myelination: a review. Acta Neurologica Bélgica, 1, 2131.
  • BERGLES, D.E., ROBERTS, J.D.B., SOMOGYI, P. & JAHR, C.E. (2000). Glutamatergic synapses on oligodendrocyte precursor cells in the hippocampus. Nature, 405, 187191.
  • BERRIDGE, M.J., DAWSON, C.P., DOWNES, C.P., HELSOP, J.P. & IRVINE, R.F. (1983). Changes in the levels of inositol phosphates after agonist-dependent hydrolysis of membrane phosphoinositides. Biochem. J., 212, 473482.
  • CHAVKIN, C., MCLAUGHLIN, J.P. & CELVER, J.P. (2001). Regulation of opioid receptor function by chronic agonist exposure: constitutive activity and desensitization. Mol. Pharmacol., 60, 2025.
  • COHEN, R.I. & ALMAZAN, G. (1994). Rat oligodendrocytes express muscarinic receptors coupled to phosphoinositide hydrolysis and adenylyl cyclase. Eur. J. Neurosci., 6, 12131224.
  • COHEN, R.I., MOLINA-HOLGADO, E. & ALMAZAN, G. (1996). Carbachol stimulates c-fos expression and proliferation in oligodendrocyte progenitors. Mol. Brain Res., 43, 193201.
  • DEBBURMAN, S.K., KUNAPULI, P., BENOVIC, J.L. & HOSEY, M.M. (1995). Agonist-dependent phosphorylation of human muscarinic receptors in Spodoptera frugiperda insect cell membranes by G protein-coupled receptor kinases. Mol. Pharmacol., 47, 224233.
  • EVA, C., RICCI, S., GENAZZANI, E. & COSTA, E. (1990). Molecular mechanism of homologous desensitization and internalization of muscarinic receptors in primary cultures of neonatal neurons. J. Pharmacol. Exp. Ther., 253, 257265.
  • FISHER, S.K. (1988). Recognition of muscarinic cholinergic receptors in human SK-N-SH neuroblastoma cells by quaternary and tertiary ligands is dependent upon temperature, cell integrity, and the presence of agonists. Mol. Pharmacol., 33, 414422.
  • FITZGERALD, U.F. & BARNETT, S.C. (2000). AP-1 activity during growth, differentiation and death of O-2A lineage cells. Mol. Cell. Neurosci., 16, 453469.
  • GAINETDINOV, R.R., BOHN, L.M., WALKER, J.K., LAPORTE, S.A., MACRAE, A.D., CARON, M.G., LEFKOWITZ, R.J. & PREMONT, R.T. (1999). Muscarinic supersensitivity and impaired receptor desensitization in G protein-coupled receptor kinase 5-deficient mice. Neuron, 4, 10291036.
  • GUREVICH, V.V., DION, S.B., ONORATO, J.J., PTASIENSKI, J., KIM, C.M., STERNE-MARR, R., HOSEY, M.M. & BENOVIC, J.L. (1995). Arrestin interactions with G protein-coupled receptors. Direct binding studies of wild type and mutant arrestins with rhodopsin, beta 2-adrenergic, and m2 muscarinic cholinergic receptors. J. Biol. Chem., 270, 720731.
  • HADDAD, E.-B.H., ROUSELL, J. & BARNES, P.J. (1995). Muscarinic M2 receptor synthesis: study of receptor turnover with propylbenzilylcholine mustard. Eur. J. Pharmacol., 290, 201205.
  • HAUSDORFF, W.P., CARON, M.G. & LEFKOWITZ, R.J. (1990). Turning off the signal: desensitization of β-adrenergic function. FASEB J., 4, 28812889.
  • HEUSER, J.E. & ANDERSON, R.G.W. (1989). Hypertonic media inhibit receptor-mediated endocytosis by blocking clathrin-coated pit formation. J. Cell Biol., 108, 389400.
  • KASTRITSIS, C.H. & MCCARTHY, K.D. (1993). Oligodendroglial lineage cells express neuroligand receptors. Glia, 8, 106113.
  • LAROCCA, J.N. & ALMAZAN, G. (1997). Acetylcholine agonists stimulate mitogen-activated protein kinase in oligodendrocyte progenitors by muscarinic receptors. J. Neurosci. Res., 50, 743750.
  • LOHSE, M.J. (1993). Molecular mechanism of membrane receptor desensitization. Biochem. Biophys. Acta, 1179, 171188.
  • LOHSE, M.J., BENOVIC, J.L., CODINA, J., CARON, M.G. & LEFKOWITZ, R.J. (1990). beta-Arrestin: a protein that regulates beta-adrenergic receptor function. Science, 248, 15471550.
  • MCCARTHY, K.D. & DE VELLIS, J. (1980). Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J. Cell Biol., 85, 890902.
  • MCPHERSON, G.A. (1985). Analysis of radioligand binding experiments: A collection of computer programs for the IBM PC. J. Pharmacol. Meth., 14, 213228.
  • MUNSON, P.J. & RODBARD, D. (1980). LIGAND: A versatile computerized approach for characterization of ligand-binding systems. Ann. Biochem., 107, 220239.
  • PALS-RYLAARSDAM, R., XU, Y., WITT-ENDERBY, P., BENOVIC, J.L. & HOSEY, M.M. (1995). Desensitization and internalization of the m2 muscarinic acetylcholine receptor are directed by independent mechanisms. J. Biol. Chem., 270, 2900429011.
  • PEARCE, B., MORROW, C. & MURPHY, S. (1988). Characteristics of phorbol ester- and agonist-induced down-regulation of astrocyte receptors coupled to inositol phospholipid metabolism. J. Neurochem., 50, 936944.
  • PENDE, M., FISHER, T.L., SIMPSON, P.B., RUSSELL, J.T., BLENIS, J. & GALLO, V. (1997). Neurotransmitter- and growth factor-induced cAMP response element binding protein phosphorylation in glial cell progenitors: role of calcium ions, protein kinase C, and mitogen activated protein kinase/ribosomal S6 kinase pathway. J. Neurosci., 17, 12911301.
  • PIPPIG, S., ANDEXINGER, S. & LOHSE, M. (1995). Sequestration and recycling of β2-adrenergic receptors permit receptor resensitization. Mol. Pharmacol., 7, 666676.
  • PITCHER, J.A., FREEDMAN, N.J. & LEFKOWITZ, R.J. (1998). G protein-coupled receptor kinases. Annu. Rev. Biochem., 67, 653692.
  • RAGHEB, F., MOLINA-HOLGADO, E., CUI, Q.L., KHORCHID, A., LIU, H.N., LAROCCA, J.N. & ALMAZAN, G. (2001). Pharmacological and functional characterization of muscarinic receptor subtypes in developing oligodendrocytes. J. Neurochem., 77, 13961406.
  • RITCHIE, T., COLE, R., KIM, H., DE VELLIS, J. & NOBLE, E.P. (1987). Inositol phospholipid hydrolysis in cultured astrocytes and oligodendrocytes. Life Sci., 41, 3139.
  • SATO-BIGBEE, C., PAL, S. & CHU, A.K. (1999). Different neuroligands and signal transduction pathways stimulate CREB phosphorylation at specific developmental stages along oligodendrocyte differentiation. J. Neurochem., 72, 139147.
  • SLOWIEJKO, S.D., MCEWEN, E.L., ERNST, S.A. & FISHER, S.K. (1996). Muscarinic receptor sequestration in SH-SY5Y neuroblastoma cells is inhibited when clathrin distribution is perturbed. J. Neurochem., 66, 186196.
  • SOLIVEN, B., SZUCHET, S., ARNASON, B.G. & NELSON, D.J. (1988). Voltage-gated potassium currents in cultured ovine oligodendrocytes. J. Neurosci., 8, 21312141.
  • SONTHEIMER, H., TROTTER, J., SCHACHNER, M. & KETTENMANN, H. (1989). Channel expression correlates with differentiation stage during the development of oligodendrocytes from their precursor cells in culture. Neuron, 2, 11351145.
  • TAKEDA, M., NELSON, D.J. & SOLIVEN, B. (1995). Calcium signalling in cultured rat oligodendrocytes. Glia, 14, 225236.
  • THOMPSON, A.K. & FISHER, S.K. (1990). Relationship between agonist-induced muscarinic receptor loss and desensitization of stimulated phosphoinoside turnover in two neuroblastomas: methodological considerations. J. Pharmacol. Exp. Ther., 252, 744752.
  • TOBIN, A.B. & NAHORSKI, S.R. (1993). Rapid agonist-mediated phosphorylation of m3-muscarinic receptors revealed by immunoprecipitation. J. Biol. Chem., 268, 98179823.
  • TSAO, P. & VON ZASTROW, M. (2000). Downregulation of G-protein-coupled receptors. Curr. Opin. Neurobiol., 10, 365369.
  • TSUGA, H., OKUNO, E., KAMEYAMA, K. & HAGA, T. (1998). Sequestration of human muscarinic acetylcholine receptor hm1-hm5 subtypes: effect of G protein-coupled receptor kinases GRK2, GRK4, GRK5 and GRK6. J. Pharmacol. Exp. Ther., 284, 12181226.
  • WILLETS, J.M., CHALLISS, R.A., KELLY, E. & NAHORSKI, S.R. (2001). G protein-coupled receptor kinases 3 and 6 use different pathways to desensitize the endogenous M3 muscarinic acetylcholine receptor in human SH-SY5Y cells. Mol. Pharmacol., 60, 321330.
  • XU, J. & CHUANG, D.-M. (1987). Muscarinic acetylcholine receptor-mediated phosphoinositide turnover in cultured cerebellar granule cell: desensitization by receptor agonists. J. Pharmacol. Exp. Ther., 242, 238244.
  • YANG, J., WILLIAMS, J.A., YULE, D.I. & LOGSDON, C.D. (1995). Mutation of carboxyl-terminal threonine residues in human m3 muscarinic acetylcholine receptor modulates the extent of sequestration and desensitization. Mol. Pharmacol., 48, 477485.
  • YU, S.S., LEFKOWITZ, R.J. & HAUSDORFF, W.P. (1993). β-adrenergic receptor sequestration: a potential mechanism of receptor resensitization. J. Biol. Chem., 268, 337341.